| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.0089 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |